TPST: Tempest Therapeutics, Inc. Stock

by  •  • Comments Off on TPST: Tempest Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 38.21
Enterprise Value ($M) 16.49
Book Value ($M) 20.63
Book Value / Share 0.93
Price / Book 1.85
NCAV ($M) 9.75
NCAV / Share 0.44
Price / NCAV 3.92

Profitability (mra)
Return on Invested Capital (ROIC) -0.73
Return on Assets (ROA) -0.97
Return on Equity (ROE) -5.94

Liquidity (mrq)
Quick Ratio 3.13
Current Ratio 3.13

Balance Sheet (mrq) ($M)
Current Assets 33.50
Assets 44.38
Liabilities 23.75
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -29.16
Net Income -29.49
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -27.36
Cash from Investing -0.17
Cash from Financing 35.60

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
05-13 13D/A Versant Venture Capital VI, L.P. 9.50 0.00
02-14 13G/A Rock Springs Capital Management LP 0.00 -100.00
02-14 13G/A EcoR1 Capital, LLC 0.00 -100.00
02-09 13G/A Fmr Llc 2.24 -33.33

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-19 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K
2023-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-07-26 104,309 395,705 26.36
2024-07-25 114,161 401,868 28.41
2024-07-24 87,289 429,830 20.31
2024-07-23 180,357 671,383 26.86
2024-07-22 76,033 531,838 14.30

(click for more detail)

Similar Companies
TIL – Instil Bio, Inc. TLSA – Tiziana Life Sciences Ltd
TNXP – Tonix Pharmaceuticals Holding Corp. TRAW – Traws Pharma, Inc.
TRVN – Trevena, Inc.


Financial data and stock pages provided by
Fintel.io